Information for Investors
Corcept Therapeutics is a pharmaceutical company engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders, with a focus on disorders associated with the steroid hormone cortisol.
Corcept Therapeutics IncorporatedSymbol: CORT
Stock Quote at 10/22/2016 5:05 ET
|Last Trade: 6.94||Days Range: 6.71 - 6.96|
|Trade Time: 4:00pm ET||52wk Range: 3.22 - 6.96|
|Change: +0.06 (0.87%)||Volume: 425,860|
|Prev Close: 6.88||Open: 6.82|
|Bid: 5.00||P/E: 771.11|
|Ask: 10.00||EPS: 0.01|
Quotes delayed up to 30 minutes
Investor Relations Contact Information
Sign up to receive Corcept press releases via email
Quotes are provided by EDGAR Online and are delayed at least 20 minutes. Corcept Therapeutics is not responsible for the accuracy of this information or any actions that may be taken based on this information. Current and historical stock price data is not necessarily indicative of future performance.